Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Spironolactone for hypertension

Esta versión no es la más reciente

Información

DOI:
https://doi.org/10.1002/14651858.CD008169Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 07 octubre 2009see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:
  1. Grupo Cochrane de Hipertensión

Copyright:
  1. Copyright © 2010 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Aaron M Tejani

    Correspondencia a: Clinical Research and Drug Information, Fraser Health Authority, Burnaby, Canada

    [email protected]

  • Curt T Fowkes

    Pharmacy, Northern Health Authority, Prince George, Canada

  • Josh Batterink

    Pharmacy, Northern Health Authority, Prince George, Canada

Contributions of authors

All three authors will be responsible for searching for trials, data extraction, data analyses, interpretation of data, and writing/editing of the final report.

Sources of support

Internal sources

  • Fraser Health Authority, Canada.

  • Northern Health Authority, Canada.

External sources

  • No sources of support supplied

Declarations of interest

Curt Fowkes has no perceived or actual conflicts of interest to declare.

Josh Batterink has no perceived or actual conflicts of interest to declare.

Aaron M Tejani has no perceived or actual conflicts of interest to declare for the past 6 years.

Acknowledgements

The authors would like to acknowledge the original authors of this protocol (Pillay A, Freemantle N, Griffin CC, Hill S, O' Reagan LL) who identified the topic and contributed extensive background work on the protocol.

The authors would also like to acknowledge the assistance provided by the Cochrane Hypertension Group.

Version history

Published

Title

Stage

Authors

Version

2010 Aug 04

Spironolactone for hypertension

Review

Josh Batterink, Sarah N Stabler, Aaron M Tejani, Curt T Fowkes

https://doi.org/10.1002/14651858.CD008169.pub2

2009 Oct 07

Spironolactone for hypertension

Protocol

Aaron M Tejani, Curt T Fowkes, Josh Batterink

https://doi.org/10.1002/14651858.CD008169

Keywords

MeSH

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.